CLINICAL_TRIALS
trial_result
· 2012-02-07
Clinical Trial Update: SUBLIVAC® Birch PROBE Study [Phase 2]
Summary
A Phase 2 trial of SUBLIVAC Birch PROBE for birch pollen allergy and seasonal allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HAL Allergy | Conditions: Seasonal Rhinitis and/or Rhinoconjunctivitis, Birch Pollen Allergy | Phase 2 | Status: COMPLETED